Get latest articles and stories on India at LatestLY. Adar Poonawalla said that the availability of the Human Papillomavirus (HPV) vaccine will be little in number this year, however, it would be boosted next year. India News | Vaccine for Cervical Cancer Prevention to Be Available in Small Quantity in 2023, Increased Next Year: Adar Poonawalla.
A day after the launch of the first made-in-India Human Papillomavirus (HPV) CERVAVAC vaccine for the prevention of cervical cancer, Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla on Wednesday said that the availability of the vaccine will be little in number this year, however, it would be boosted next year.
Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla, on Tuesday announced the launch of the first made-in-India Human Papillomavirus (HPV) CERVAVAC vaccine, for the prevention of cervical cancer.